Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cells for Chronic Kidney Disease
NCT07240987Phase 2Not yet recruiting
- Sponsor
- Xijing Hospital
- Start
- Jan 2026
- Primary completion
- Aug 2027
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of umbilical cord tissue-derived mesenchymal stem cells in chronic kidney disease (CKD), diabetic kidney disease (DKD), hypertensive nephropathy (HN), sponsored by Xijing Hospital. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
umbilical cord tissue-derived mesenchymal stem cells
03
Conditions
chronic kidney disease (CKD)diabetic kidney disease (DKD)hypertensive nephropathy (HN)
Beyond the preview
Go deeper on NCT07240987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07240987.